Nearly half of young women who are breast cancer survivors experienced sexual dysfunction more than 5 years after diagnosis. Referral sources should “be mindful of the language used” and a patient’s ability to access services. Features of accelerated tissue aging were discovered in carriers of germline mutations in BRCA1 or BRCA2. Hormonal contraception is associated with a 20-30% relative increase in risk for those with a BRCA1 pathogenic variant. Survival rates have not improved even when adjusting for treatment and clinicopathological features. Improving diversity in trial participation may help researchers understand differences in tumor biology.